Dose Individualization of Antineoplastic Drugs and Anti-Infective Drug in Children With Hematoplastic Disease

NCT03844360 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

1500

Enrollment

OTHER

Sponsor class

Conditions

Hematological Neoplasms

Interventions

DRUG: Bortezomib
DRUG: Eltrombopag
DRUG: Imatinib
DRUG: dasatinib
DRUG: Pegaspargase
DRUG: Anti-Infective Drugs
DRUG: PEGylated Recombinant Human Granulocyte Colony-Stimulating Factor

Sponsor

Wei Zhao

Collaborators

[object Object]